blood

AstraZeneca (AZN) has had a good week with its anticlotting drug Brilinta (ticagrelor). It impressed many observers by announcing positive results of a late-stage head-to-head study and a mid-stage study for Brilinta, and on Thursday, it said it had filed for Food and Drug Administration approval....

It seems that when it comes to Aranesp, its blockbuster anemia drug, Amgen (AMGN) just can't catch a break, nor for that matter, create one. Recently, Amgen was hit with a double whammy -- a lawsuit and an unfavorable study of the drug. On Tuesday, yet another study confirmed that cancer patients...

The Stanford Blood Center has come up with a new way to get people to donate blood: Job hunting help for the unemployed. Job hunting hurts, much like the prick of a needle can hurt. But the pain shouldn't be enough to stop job seekers from donating something that can save a life. For 300...